Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Non-metastatic Prostate Cancer × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1375 Neoplasms 1157 Colorectal Neoplasms 617 Lung Neoplasms 551 Prostatic Neoplasms 532 Carcinoma, Non-Small-Cell Lung 440 Carcinoma, Hepatocellular 289 Stomach Neoplasms 269 Pancreatic Neoplasms 266 Colonic Neoplasms 263 Ovarian Neoplasms 227 Head and Neck Neoplasms 221 Rectal Neoplasms 218 Melanoma 214 Multiple Myeloma 201 Uterine Cervical Neoplasms 196 Lymphoma 192 Leukemia 192 Precursor Cell Lymphoblastic Leukemia-Lymphoma 188 Neoplasm Metastasis 177 Carcinoma, Renal Cell 175 Esophageal Neoplasms 172 Brain Neoplasms 170 Leukemia, Myeloid, Acute 156 Urinary Bladder Neoplasms 138 Polycystic Ovary Syndrome 121 Recurrence 120 Liver Neoplasms 118 Hematologic Neoplasms 117 Endometrial Neoplasms 106

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06204302 2024-04-09

ARENA

Bayer

Non-metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡